Webinar
Investing for a Post-AGI World
Join Matt Caspari, Managing Partner of Alumni Ventures’ Deep Tech Fund, as he explores how investors can prepare for a future shaped by artificial general intelligence — and where durable value may emerge as technology rapidly evolves.
Matt will examine what a post-AGI world could mean for technology, markets, and venture investing. He’ll discuss how increasingly capable AI may reshape competitive advantages and the way investors evaluate long-term opportunities.
Whether you’re closely following AI or considering how transformative technologies may affect your portfolio, this session will offer a grounded framework for thinking beyond today’s market. Register to explore how investors can prepare for the possibilities — and uncertainties — of a post-AGI future.
Want to access our Deep Tech Fund startup deals to see, evaluate, and optionally invest? No cost, no commitment.
Why Attend?
- HomeExplore what AGI could mean for technology and venture investing
- HomeUnderstand how investors can evaluate long-term opportunities amid rapid change
- HomeConsider how to prepare a venture portfolio for a potential post-AGI future
Rated a Top 20 VC Firm by both TIME and CB Insights.
Alumni Ventures is America’s largest venture capital firm for individual investors.
About your presenter
Overview
Matt Caspari invests in mission-driven founders building the next generation of iconic companies—entrepreneurs tackling the world’s hardest, highest-stakes problems. He backs breakthrough technologies with the potential to redefine critical industries, unlock new markets, and create a more sustainable, secure future.
Before Alumni Ventures, Matt was a two-time venture-backed founder/CEO and a leader of the innovation team at Nike. He founded Aurora Biofuels, a deep-tech venture that grew to 100+ employees and secured more than $100 million in funding before its acquisition by Reliance Industries. Earlier, he advised life science multinationals at Cambridge Pharma Consultancy (acquired by IMS Health) and gained experience on Bloomberg’s M&A team. Matt holds a BS in Biochemistry from Georgetown University and an MBA with a Certificate in Entrepreneurship from UC Berkeley.
Funds actively worked on
Investment Area of Focus
His investment lens favors bold solutions to global challenges and durable advantages rooted in technology and aligned with long-term megatrends. This translates to surgical robots powered by physical AI, next-generation energy systems, space-based infrastructure, longevity therapeutics, and more. The through-line is the potential for extraordinary value creation at the intersection of deep science and global need.
Representative investments Matt has led for Alumni Ventures include Andromeda Surgical and Cytronic (Physical AI); Arda Therapeutics and Cambrian Biopharma (Technologies for the Human Body); Max Space and Orbital Operations (Space Infrastructure); and Fortera and Mainspring Energy (The New Energy Stack). Alumni Ventures’ Deep Tech portfolio also includes companies such as Axiom Space, Ayar Labs, Cohere, Frore Systems, Groq, Hawkeye360, Hayden AI, Lambda, Radiant, and Rigetti (Nasdaq: RGTI).